| CTRI Number |
CTRI/2024/05/066955 [Registered on: 07/05/2024] Trial Registered Prospectively |
| Last Modified On: |
02/05/2024 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Biological |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Effectiveness of Platelet Rich Plasma (PRP) Injection versus Steroid injection for Knee pain in patients with Rheumatoid Arthritis (RA) – A Single blind Randomized control Trial |
|
Scientific Title of Study
|
Efficacy of Local Intra-articular Platelet Rich Plasma (PRP) Injection versus Steroids for Knee Rheumatoid Arthritis (RA) – A Single blind Randomized control Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Bismaya Sahoo |
| Designation |
Assistant Professor |
| Affiliation |
All India Institute of Medical Sciences Kalyani |
| Address |
Department of Orthopaedics
All India Institute of Medical Sciences Kalyani Saguna Basantapur Nadia West Bengal Nadia WEST BENGAL 741245 India |
| Phone |
9147062857 |
| Fax |
|
| Email |
bismaya.aiims@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Bismaya Sahoo |
| Designation |
Assistant Professor |
| Affiliation |
All India Institute of Medical Sciences Kalyani |
| Address |
Department of Orthopaedics
All India Institute of Medical Sciences Kalyani Saguna Basantapur Nadia West Bengal Nadia WEST BENGAL 741245 India |
| Phone |
9147062857 |
| Fax |
|
| Email |
bismaya.aiims@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Bismaya Sahoo |
| Designation |
Assistant Professor |
| Affiliation |
All India Institute of Medical Sciences Kalyani |
| Address |
Department of Orthopaedics
All India Institute of Medical Sciences Kalyani Saguna Basantapur Nadia West Bengal Nadia WEST BENGAL 741245 India |
| Phone |
9147062857 |
| Fax |
|
| Email |
bismaya.aiims@gmail.com |
|
|
Source of Monetary or Material Support
|
| All India Institute of Medical Sciences Kalyani, Saguna, Basantapur, Kalyani, Nadia, West Bengal, India
PIN- 741245 |
|
|
Primary Sponsor
|
| Name |
All India Institute of Medical Sciences Kalyani |
| Address |
Saguna, Basantapur, Kalyani, Nadia, West Bengal, India
Pin- 741245 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Bismaya Sahoo |
All India Institute of Medical Sciences Kalyani |
4th floor , OPD BUIlding, Department of Orthopaedics, Room no. 3, Saguna, Basantapur, Kalyani, Nadia, West Bengal, India
Pin- 741245 Nadia WEST BENGAL |
9147062857
bismaya.ortho@aiimskalyani.edu.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, All India Institute of Medical Sciences, Kalyani |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M059||Rheumatoid arthritis with rheumatoid factor, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Local Intra-articular Platelet Rich Plasma (PRP) Injection for Knee Rheumatoid Arthritis (RA) |
Patients will be randomly divided into two subgroups. In group 1, the patients will receive 3 doses of intrarticular PRP inj of 5ml each in the affected knee. Under complete aseptic condition, 1 month apart. PRP will be prepared from the autologous venous blood by using centrifuge. All patients will be assessed at baseline, 3 months and 6 month |
| Comparator Agent |
Local Intra-articular Injection of Steroids for Knee Rheumatoid Arthritis (RA) |
In group 2, the patients will receive a single dose of local Intra-articular inj. Triamcinolone 40mg mixed with 3ml of 2% Lignocaine, in affected Knee joint. All patients will be assessed at baseline, 3 months and 6 months |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
1. All patients aged ≥18 years who are fulfilling 2010 ACR-EULAR classification criteria for RA.
2. Patients having low disease activity as per DAS28 criteria.
3. Patients treated with DMARD for at least 3 months with stable conditions.
4. Patients who will give consent for inclusion in the study.
|
|
| ExclusionCriteria |
| Details |
Trauma history, local abscess, septic arthritis, patients on opioids analgesics, malignancy, pregnancy, HCV, HBV infected patients, blood disorders (coagulopathy, thrombocytopenia), and patients with previous intra-articular injection of steroid or PRP (within past 6 months). |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| VAS Score, HAQ-DI Score, Swelling score, tenderness score, and USG finding |
baseline, 3 months and 6 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Demographic data and disease severity |
baseline, 3 months and 6 months |
|
|
Target Sample Size
|
Total Sample Size="52" Sample Size from India="52"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
10/07/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Title: Efficacy of Local Intra-articular Platelet Rich Plasma (PRP) Injection versus Steroids for Knee Rheumatoid Arthritis (RA) – A Single blind Randomized control Trial. Background: Rheumatoid Arthritis (RA) in the knee is a debilitating manifestation of systemic autoimmune disease, causing inflammation, pain, and functional impairment. This study aims to compare the effectiveness of local intra-articular Platelet Rich Plasma (PRP) injections and steroids in managing knee RA-related inflammation, pain, and quality of life. Objective: To evaluate and compare the outcomes of local intra-articular PRP injection and intra-articular steroids in terms of pain alleviation, reduction in joint inflammation, disease activity, and improvement in quality of life in patients with knee RA. Methodology: Study Design: This will be a single-blind randomized controlled trial. Study Setting: The study will take place in the Outpatient Department (OPD) of the Department of Orthopaedics at AIIMS Kalyani. Participants: Patients aged ≥18 years fulfilling the 2010 ACR-EULAR classification criteria for RA and having low disease activity will be included. Sample Size: The calculated sample size is 26 participants in each group, considering a 20% dropout rate. Intervention Groups: Group 1 (PRP): Participants will receive three doses of local intra-articular PRP injection of 5ml each prepared from autologous venous blood, administered one month apart. Group 2 (Steroids): Participants will receive a single dose of intra-articular triamcinolone 40mg mixed with 3ml of 2 percent Lignocaine. Outcome Measures: Participants will be assessed at baseline, 3 months, and 6 months after intervention. Outcome measures include: Visual Analog Scale (VAS) for pain assessment. Health Assessment Questionnaire-Disability Index (HAQ-DI) for functional status. Swelling score and tenderness score for joint inflammation. Ultrasound findings for joint assessment. Data Analysis: Data will be entered into Microsoft Excel and analyzed using SPSS v25.0 and Dxt v1.0 software. Continuous variables will be expressed as means with standard deviations, and categorical data will be presented as proportions. Statistical significance will be set at P < 0.05. Intention-to-treat analysis will be performed, and additional statistical tests will be carried out if necessary. Significance: This study addresses the need for effective local management of knee RA symptoms, focusing on pain reduction and inflammation control. By comparing PRP injections and steroids, we aim to contribute insights into improved therapeutic options for enhancing the quality of life and well-being of individuals with knee RA. Conclusion: By conducting a rigorous randomized controlled trial, we hope to shed light on the potential benefits of local intra-articular PRP injection as an innovative therapeutic approach for knee RA. The findings could influence clinical practice and offer patients a more effective and well-tolerated treatment option. |